Skip to main content

Table 4 Prevalence of complications and comorbidities in RA cases stratified by age and sex

From: Prevalence, comorbidities, and disease-related complications of rheumatoid arthritis in Colombia: a national cross-sectional study based on administrative claims data

Variables

Age group

Sex

Total

18–49

(n = 33,624)

50–64

(n = 48,580)

65–74

(n = 24,964)

≥ 75

(n = 15,912)

Female (n = 101,105)

Male

(n = 21,975)

Infectious complications

       

Viral and bacterial pneumonia

5.91 (5.66–6.18)

8.71 (8.46–8.96)

12.85 (12.44–13.28)

19.40 (18.79–20.02)

9.97 (9.80–10.15)

11.07 (10.65–11.50)

10.17 (10.00–10.34)

Urinary tract infection

7.77 (7.48–8.06)

8.05 (7.80–8.30)

8.22 (7.87–8.58)

7.77 (7.35–8.21)

9.10 (8.93–9.27)

2.78 (2.57–3.01)

7.97 (7.83–8.12)

Central nervous system infection

0.53 (0.46–0.61)

0.53 (0.47–0.60)

0.66 (0.57–0.77)

0.58 (0.47–0.72)

0.54 (0.50–0.59)

0.67 (0.57–0.79)

0.56 (0.52–0.61)

Skin and subcutaneous tissue infections

19.70 (19.29–20.12)

21.35 (20.98–21.72)

21.61 (21.10–22.13)

23.15 (22.49–23.82)

20.95 (20.72–21.19)

22.25 (21.68–22.82)

21.18 (20.96–21.41)

Intestinal infectious diseases

41.44 (40.91–41.97)

33.36 (32.94–33.79)

31.15 (30.58–31.73)

31.81 (31.10–32.54)

35.34 (35.06–35.61)

33.01 (32.39–33.64)

34.92 (34.66–35.18)

Tuberculosis

2.61 (2.44–2.79)

2.98 (2.83–3.13)

2.49 (2.31–2.69)

2.06 (1.85–2.30)

2.45 (2.36–2.55)

3.62 (3.39–3.87)

2.66 (2.57–2.75)

Other bacterial diseases

0.79 (0.69–0.89)

0.74 (0.66–0.82)

0.77 (0.67–0.89)

0.88 (0.74–1.04)

0.75 (0.70–0.80)

0.91 (0.79–1.04)

0.78 (0.73–0.82)

Sexually transmitted infections

4.04 (3.83–4.26)

2.05 (1.92–2.18)

1.58 (1.43–1.74)

1.41 (1.24–1.61)

2.20 (2.12–2.29)

3.38 (3.15–3.62)

2.41 (2.33–2.50)

Viral infections

15.41 (15.01–15.81)

16.55 (16.21–16.89)

16.76 (16.30–17.23)

15.02 (14.46–15.60)

16.29 (16.08–16.51)

15.11 (14.63–15.60)

16.08 (15.88–16.29)

Viral hepatitis

1.73 (1.59–1.88)

1.58 (1.48–1.69)

1.38 (1.24–1.53)

0.90 (0.77–1.07)

1.40 (1.33–1.47)

1.93 (1.75–2.13)

1.49 (1.43–1.56)

Acute myocardial infarction

0.10 (0.07–0.14)

0.35 (0.30–0.40)

0.80 (0.69–0.92)

1.14 (0.98–1.32)

0.35 (0.31–0.39)

1.04 (0.91–1.19)

0.47 (0.44–0.51)

Musculoskeletal complications

       

Total Hip Replacement

0.23 (0.18–0.28)

0.54 (0.47–0.60)

0.79 (0.69–0.92)

0.99 (0.85–1.16)

0.55 (0.51–0.60)

0.62 (0.53–0.74)

0.56 (0.52–0.60)

Total Knee Replacement

0.15 (0.11–0.20)

0.83 (0.75–0.91)

1.65 (1.50–1.82)

1.65 (1.47–1.86)

0.92 (0.86–0.98)

0.91 (0.80–1.05)

0.92 (0.87–0.97)

Ankle Joint Replacement

0.00 (0.00–0.02)

0.01 (0.00–0.02)

0.02 (0.01–0.05)

-

0.01 (0.00–0.02)

0.01 (0.00–0.04)

0.01 (0.01–0.02)

Elbow Joint Replacement

0.02 (0.01–0.04)

0.08 (0.06–0.10)

0.09 (0.06–0.14)

0.04 (0.02–0.09)

0.06 (0.04–0.07)

0.07 (0.04–0.12)

0.06 (0.05–0.07)

Shoulder Joint Replacement

0.01 (0.01–0.03)

0.08 (0.06–0.11)

0.26 (0.21–0.34)

0.42 (0.33–0.54)

0.16 (0.13–0.18)

0.09 (0.06–0.14)

0.14 (0.12–0.17)

Comorbidities

       

Hypertension

49.92 (49.39–50.45)

65.92 (65.49–66.35)

82.44 (81.96–82.91)

91.48 (91.03–91.91)

67.91 (67.63–68.19)

69.55 (68.94–70.16)

68.20 (67.95–68.46)

Osteoarthritis

19.50 (19.09–19.92)

46.66 (46.21–47.11)

58.88 (58.27–59.49)

61.53 (60.79–62.26)

45.70 (45.41–46.00)

34.17 (33.54–34.80)

43.64 (43.37–43.91)

Gastritis

25.36 (24.91–25.81)

34.73 (34.31–35.16)

38.95 (38.35–39.56)

38.32 (37.58–39.07)

34.87 (34.59–35.14)

27.17 (26.58–27.76)

33.49 (33.24–33.75)

Hypothyroidism

22.88 (22.45–23.32)

27.91 (27.51–28.31)

35.01 (34.43–35.60)

36.91 (36.17–37.65)

31.21 (30.93–31.48)

19.62 (19.08–20.17)

29.14 (28.89–29.39)

Hyperlipidemia

8.71 (8.41–9.03)

26.36 (25.98–26.75)

30.45 (29.88–31.02)

24.77 (24.10–25.45)

22.32 (22.08–22.57)

21.43 (20.88–22.00)

22.16 (21.93–22.39)

Diabetes

7.46 (7.18–7.75)

19.46 (19.11–19.83)

30.17 (29.60–30.74)

36.56 (35.82–37.30)

20.22 (19.99–20.45)

22.14 (21.58–22.72)

20.56 (20.34–20.79)

Osteoporosis

2.94 (2.76–3.14)

15.38 (15.06–15.72)

32.59 (32.01–33.17)

39.40 (38.67–40.14)

21.09 (20.85–21.32)

7.05 (6.72–7.39)

18.58 (18.37–18.79)

Eczema

15.44 (15.05–15.85)

17.36 (17.02–17.71)

18.16 (17.69–18.64)

17.58 (17.00–18.19)

17.44 (17.22–17.66)

15.15 (14.67–15.65)

17.03 (16.82–17.24)

Discopathy

8.99 (8.68–9.31)

14.82 (14.50–15.15)

15.38 (14.94–15.83)

13.96 (13.41–14.53)

13.18 (12.99–13.38)

13.43 (12.98–13.90)

13.23 (13.04–13.42)

Anxiety

9.03 (8.72–9.35)

12.64 (12.34–12.94)

11.78 (11.39–12.20)

10.91 (10.42–11.42)

12.13 (11.94–12.32)

7.23 (6.89–7.57)

11.26 (11.08–11.43)

COPD

2.46 (2.30–2.64)

6.87 (6.65–7.10)

16.47 (16.02–16.94)

31.52 (30.81–32.24)

10.02 (9.85–10.20)

14.39 (13.92–14.87)

10.80 (10.63–10.98)

Migraine

17.30 (16.90–17.71)

11.14 (10.86–11.43)

5.67 (5.38–5.97)

3.30 (3.03–3.59)

12.03 (11.84–12.23)

4.56 (4.31–4.83)

10.70 (10.53–10.87)

GERD

5.57 (5.33–5.82)

10.95 (10.68–11.24)

12.29 (11.88–12.71)

10.86 (10.37–11.37)

10.29 (10.11–10.47)

7.21 (6.88–7.55)

9.74 (9.58–9.91)

Depression

7.86 (7.57–8.16)

10.04 (9.78–10.31)

9.09 (8.72–9.46)

9.77 (9.30–10.26)

9.79 (9.62–9.97)

6.56 (6.25–6.89)

9.22 (9.06–9.38)

Lupus

14.15 (13.78–14.54)

8.44 (8.20–8.69)

5.30 (5.03–5.60)

3.15 (2.89–3.44)

9.50 (9.33–9.68)

4.91 (4.65–5.19)

8.68 (8.53–8.84)

  1. COPD: Chronic Obstructive Pulmonary Disease; GERD: Gastroesophageal Reflux Disease. Prevalence is provided per 100 with the corresponding 95% confidence interval (CI)
  2. There were no identified hand, wrist, or spinal joint replacement cases